Literature DB >> 10401468

Improvement of sleep and behavior by methylphenidate in Alzheimer's disease.

S Kittur, P Hauser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10401468     DOI： 10.1176/ajp.156.7.1116

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  9 in total

Review 1.  Pharmacotherapies for sleep disturbances in dementia.

Authors:  Jenny McCleery; Daniel A Cohen; Ann L Sharpley
Journal:  Cochrane Database Syst Rev       Date:  2016-11-16

Review 2.  Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.

Authors:  M V Vitiello; S Borson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

3.  Relative lack of cognitive effects of methylphenidate in elderly male volunteers.

Authors:  Danielle C Turner; Trevor W Robbins; Luke Clark; Adam R Aron; Jonathan Dowson; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2003-05-07       Impact factor: 4.530

Review 4.  Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive impairment.

Authors:  Nikki Ivanchak; Kristen Fletcher; Gregory A Jicha
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

Review 5.  The role of higher-level cognitive function in gait: executive dysfunction contributes to fall risk in Alzheimer's disease.

Authors:  Pamela L Sheridan; Jeffrey M Hausdorff
Journal:  Dement Geriatr Cogn Disord       Date:  2007-07-04       Impact factor: 2.959

6.  Effects of methylphenidate on working memory in pigeons.

Authors:  Fiona K Wright; K Geoffrey White
Journal:  Cogn Affect Behav Neurosci       Date:  2003-12       Impact factor: 3.282

7.  Pharmacotherapies for sleep disturbances in dementia.

Authors:  Jenny McCleery; Ann L Sharpley
Journal:  Cochrane Database Syst Rev       Date:  2020-11-15

8.  The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial.

Authors:  Roberta W Scherer; Lea Drye; Jacobo Mintzer; Krista Lanctôt; Paul Rosenberg; Nathan Herrmann; Prasad Padala; Olga Brawman-Mintzer; William Burke; Suzanne Craft; Alan J Lerner; Allan Levey; Anton Porsteinsson; Christopher H van Dyck
Journal:  Trials       Date:  2018-01-18       Impact factor: 2.279

9.  Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer's Patients Treated with Donepezil: Case Series.

Authors:  Leszek Bidzan; Mariola Bidzan
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-06       Impact factor: 2.570
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.